Active Ingredient History

  • Now
Dexelvucitabine is a failed experimental agent for the management of human immunodeficiency virus infection. It is a cytidine nucleoside analog and nucleoside reverse transcriptase inhibitor. that inhibits HIV-1 replication in vitro. During phase II clinical trials there was some indication of a decreased mean viral load in patients with infected human immunodeficiency virus.   Wikipedia

  • SMILES: NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](CO)C=C2
  • Mol. Mass: 227.19
  • ALogP: -0.59
  • ChEMBL Molecule:
More Chemistry
2(1h)-pyrimidinone, 4-amino-1-((2s,5r)-2,5-dihydro-5-(hydroxymethyl)-2-furanyl)-5-fluoro- | 2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine | 2',3'-dideoxy-2',3'-didehydro-beta-d-5-fluorocytidine | 2',3'-dideoxy-2',3'-didehydro-beta-l-5-fluorocytidine | 4-amino-5-fluoro-1-((2s,5r)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)pyrimidin-2(1h)-one | dexelvucitabine | dpc817 | dpc 817 | dpc-817 | incb-8721 | reverset | yz-817


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue